Physician profile
Michael Brumfield
NPI 1487856670
$273.85
in general payments reported to CMS, 2019-2025
9 companies · $71.52 in 2025
The $71.52 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.68 · 2022: $18.96 · 2023: $114 · 2024: $52.52 · 2025: $71.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $43.55 | 2023-2025 | Sutab, Suflave |
| Polynovo North America LLC | $42.21 | 2023 | |
| Organogenesis INC. | $31.48 | 2023 | Puraply |
| Ethicon US, LLC | $29.98 | 2021-2023 | Enseal |
| Stryker Corporation | $29.00 | 2024 | Zipseal 16 Surgical Skin Closure Kit |
| Astrazeneca Pharmaceuticals LP | $28.26 | 2025 | |
| Daiichi Sankyo INC. | $26.89 | 2025 | Enhertu |
| Smith+Nephew, INC. | $23.52 | 2024 | Renasys Go V2 Home |
| Tela Bio, INC. | $18.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brumfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.